Eupraxia Pharmaceuticals Announces New Positive Data From RESOLVE Phase 1B/2A Trial Of EP-104GI For Treatment Of Eosinophilic Esophagitis
Source: menafn.com
James Helliwell News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from James Helliwell. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In James Helliwell Today - Breaking & Trending Today
EPRX keeps "Strong Buy" rating at Raymond James
Following the release of new data, Raymond James analyst Rahul Sarugaser remains bullish about Eupraxia Pharmaceuticals
Source: cantechletter.com
Long-Acting Steroid Gives 14 Weeks of Knee OA Relief
Placebo-controlled trial gives novel product a tentative boost
Source: medpagetoday.com
Eupraxia Pharmaceuticals is a Strong Buy, says Raymond James
Raymond James analyst Rahul Sarugaser, who delivered on Monday a report where he reiterated a Strong Buy rating on Eupraxia Pharmaceuticals.
Source: cantechletter.com